Singapore scientists uncover new fatty liver treatment in breakthrough study

Researchers from Duke-NUS Medical School and the National Heart Centre Singapore have found a possible way to treat fatty liver disease, which affects about one in four worldwide and is common in Singapore.

Assistant Professor Sebastian Schäfer from Duke-NUS Medical School and the National Heart Centre Singapore was in the studio to explain the technicalities of the treatment in layman terms. Asst Prof Schäfer is also co-founder of Enleofen Bio, the biotech company that partnered researchers for the study.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service:
WhatsApp: https://cna.asia/whatsapp
Telegram: https://t.me/cnalatest

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook:   / channelnewsasia  
Instagram:   / channelnewsasia  
Twitter:   / channelnewsasia